- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Secukinumab (AIN457)
Total 218 results
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsRecruitingModerate-to-severe Plaque PsoriasisRussian Federation
-
Novartis PharmaceuticalsAvailableHidradenitis Suppurativa (HS)
-
University of California, San FranciscoNovartis PharmaceuticalsCompleted
-
Anne ChangCompletedPapulopustular RosaceaUnited States
-
Novartis PharmaceuticalsTerminatedCrohn's Disease | Inflammatory Bowel DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedUveitisTurkey, Spain, France, Israel, Germany, Greece, Korea, Republic of, Hong Kong, United States, Egypt, Jordan, Singapore, Taiwan, Tunisia
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisUnited Kingdom, Germany, Italy, Spain, United States, Australia, Bulgaria, Russian Federation, Czechia, Canada, Netherlands, Switzerland, Puerto Rico
-
Chinese University of Hong KongCompleted
-
Jinnah Postgraduate Medical CentreCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Novartis PharmaceuticalsCompleted
-
Beth Israel Deaconess Medical CenterNovartis PharmaceuticalsTerminatedNecrobiosis Lipoidica DiabeticorumUnited States
-
Novartis PharmaceuticalsCompletedHidradenitis SuppurativaBelgium, Italy, United Kingdom, United States, Hungary, Malaysia, Germany, Netherlands, France, Israel, Lebanon, Singapore, Spain, Bulgaria, Lithuania, Argentina, Turkey, Guatemala, Switzerland, Vietnam, Philippines, Croatia, India, S... and more
-
Novartis PharmaceuticalsWithdrawnActive Peripheral Spondyloarthritis (pSpA)
-
Massachusetts General HospitalNovartisWithdrawnDiscoid Lupus ErythematosusUnited States
-
Icahn School of Medicine at Mount SinaiNovartisTerminated
-
Diamant ThaciNovartisCompleted
-
Tanja Todberg, MDUnknown
-
Novartis PharmaceuticalsTerminatedType 1 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisSpain, United Kingdom, Estonia, Germany, Bulgaria, Finland, Hungary, Poland, Argentina, Canada, Denmark, Switzerland, Sweden
-
Novartis PharmaceuticalsTerminatedCrohn's DiseaseGermany
-
Novartis PharmaceuticalsCompletedRheumatoid ArthritisNetherlands, Germany, Belgium, Singapore, Spain, United States
-
University of PennsylvaniaNovartisRecruiting
-
Novartis PharmaceuticalsCompletedAnkylosing SpondylitisUnited States, Germany, Netherlands, United Kingdom
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, Japan, France, Norway, Israel, Iceland
-
Novartis PharmaceuticalsRecruitingPolymyalgia RheumaticaAustralia
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPsoriasis, Plaque-type PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, France, Estonia, Canada
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
Novartis PharmaceuticalsTerminatedNon-infectious UveitisSpain, Switzerland, United States, Germany, United Kingdom, Israel, Brazil, India
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisGermany, United Kingdom, United States, Belgium, Philippines, Singapore, Thailand, Brazil, Czech Republic, Italy, Argentina, Israel, Russian Federation, Bulgaria, Romania, Australia, Canada, Poland, Slovakia
-
Novartis PharmaceuticalsCompletedAnkylosing SpondylitisGermany, Belgium, Netherlands, France, United States, Bulgaria, Italy, Russian Federation, Peru, United Kingdom, Canada, Mexico, Taiwan, Turkey
-
Livzon Pharmaceutical Group Inc.Recruiting
-
University of MiamiNovartisRecruiting
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisChina, Thailand, Philippines, Turkey, Hungary, Malaysia
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisUnited States, Austria, Germany, France, Japan, Canada, Slovakia, India
-
Novartis PharmaceuticalsCompletedArthritis, PsoriaticUnited States, Italy, Germany, Australia, Belgium, Poland, Bulgaria, Russian Federation, Czechia, Canada, France, Sweden, United Kingdom
-
Wake Forest University Health SciencesNovartisWithdrawnPyoderma Gangrenosum
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisGermany, Netherlands, United Kingdom
-
Northwestern UniversityIcahn School of Medicine at Mount SinaiCompletedNetherton Syndrome | Ichthyosis | Lamellar Ichthyosis | Autosomal Recessive Congenital Ichthyosis | Congenital Ichthyosiform Erythroderma | Epidermolytic IchthyosisUnited States
-
Janssen Research & Development, LLCCompleted
-
Novartis PharmaceuticalsCompletedPeriodic Fevers SyndromeJapan
-
Novartis PharmaceuticalsWithdrawn